Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 13Takeda Pharmaceutical

02 1Takeda Pharmaceuticals Australia Pty. Ltd.

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Pharma MES 2025
Not Confirmed
arrow
arrow
Pharma MES 2025
Not Confirmed

LANADELUMAB-FLYO

Brand Name : TAKHZYRO

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 300MG/2ML (150MG/ML)

Packaging :

Approval Date :

Application Number : 761090

Regulatory Info :

Registration Country : USA

blank

02

Pharma MES 2025
Not Confirmed
arrow
arrow
Pharma MES 2025
Not Confirmed

LANADELUMAB-FLYO

Brand Name : TAKHZYRO

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 300MG/2ML (150MG/ML)

Packaging :

Approval Date :

Application Number : 761090

Regulatory Info :

Registration Country : USA

blank

03

Pharma MES 2025
Not Confirmed
arrow
arrow
Pharma MES 2025
Not Confirmed

Lanadelumab

Brand Name : Takhzyro

Dosage Form : Solution For Injection

Dosage Strength : 150mg

Packaging :

Approval Date : 15/11/2023

Application Number : 20221110000085

Regulatory Info : Approved

Registration Country : Sweden

blank

04

Pharma MES 2025
Not Confirmed
arrow
arrow
Pharma MES 2025
Not Confirmed

Lanadelumab

Brand Name : Takhzyro

Dosage Form : Injectable Solution

Dosage Strength : 300mg

Packaging :

Approval Date : 22/11/2018

Application Number : 20180509000016

Regulatory Info : Approved

Registration Country : Sweden

blank

05

Pharma MES 2025
Not Confirmed
arrow
arrow
Pharma MES 2025
Not Confirmed

Lanadelumab

Brand Name : Takhzyro

Dosage Form : Solution For Injection

Dosage Strength : 300mg

Packaging :

Approval Date : 13/02/2025

Application Number : 20241128000075

Regulatory Info : Approved

Registration Country : Sweden

blank

06

Pharma MES 2025
Not Confirmed
arrow
arrow
Pharma MES 2025
Not Confirmed

Lanadelumab

Brand Name : Takhzyro

Dosage Form : Solution For Injection

Dosage Strength : 300mg

Packaging :

Approval Date : 07/05/2020

Application Number : 20200219000011

Regulatory Info : Approved

Registration Country : Sweden

blank

07

Pharma MES 2025
Not Confirmed
arrow
arrow
Pharma MES 2025
Not Confirmed

Lanadelumabum

Brand Name : TAKHZYRO

Dosage Form : Solution For Injection

Dosage Strength : 300mg/2ml

Packaging :

Approval Date : 05/11/2020

Application Number : 68178

Regulatory Info : Allowed

Registration Country : Switzerland

blank

08

Pharma MES 2025
Not Confirmed
arrow
arrow
Pharma MES 2025
Not Confirmed

Lanadelumabum

Brand Name : TAKHZYRO

Dosage Form : Solution For Injection

Dosage Strength : 150mg/ml

Packaging :

Approval Date : 05/11/2020

Application Number : 68178

Regulatory Info : Allowed

Registration Country : Switzerland

blank

09

Pharma MES 2025
Not Confirmed
arrow
arrow
Pharma MES 2025
Not Confirmed

LANADELUMAB

Brand Name : TAKHZYRO

Dosage Form : SOLUTION

Dosage Strength : 300MG/2ML

Packaging : 2ML

Approval Date :

Application Number : 2480948

Regulatory Info : Prescription

Registration Country : Canada

blank

10

Pharma MES 2025
Not Confirmed
arrow
arrow
Pharma MES 2025
Not Confirmed

LANADELUMAB

Brand Name : TAKHZYRO

Dosage Form : SOLUTION

Dosage Strength : 300MG/2ML

Packaging :

Approval Date :

Application Number : 2505614

Regulatory Info : Schedule D

Registration Country : Canada

blank

11

Pharma MES 2025
Not Confirmed
arrow
arrow
Pharma MES 2025
Not Confirmed

Lanadelumab

Brand Name : Takhzyro

Dosage Form : Injectable Solution In Pre-Filled Syringe

Dosage Strength : 150MG

Packaging :

Approval Date : 2024-01-18

Application Number : 1181340007

Regulatory Info : Authorized

Registration Country : Spain

blank

12

Pharma MES 2025
Not Confirmed
arrow
arrow
Pharma MES 2025
Not Confirmed

Lanadelumab

Brand Name : Takhzyro

Dosage Form : Injectable Solution

Dosage Strength : 300MG

Packaging :

Approval Date : 2019-03-28

Application Number : 1181340001

Regulatory Info : Authorized

Registration Country : Spain

blank

13

Pharma MES 2025
Not Confirmed
arrow
arrow
Pharma MES 2025
Not Confirmed

Lanadelumab

Brand Name : Takhzyro

Dosage Form : Injectable Solution In Pre-Filled Syringe

Dosage Strength : 300MG

Packaging :

Approval Date : 2020-09-09

Application Number : 1181340004

Regulatory Info : Authorized

Registration Country : Spain

blank

14

Takeda Pharmaceuticals Australia Pt...

Country
Pharma MES 2025
Not Confirmed
arrow

Takeda Pharmaceuticals Australia Pt...

Country
arrow
Pharma MES 2025
Not Confirmed

Lanadelumab

Brand Name : Takhzyro

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank